Cite
HARVARD Citation
Qureshi, M. et al. (2021). Safety and efficacy of (+)‐epicatechin in subjects with Friedreich's ataxia: A phase II, open‐label, prospective study. Journal of inherited metabolic disease. 44 (2), pp. 502-514. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Qureshi, M. et al. (2021). Safety and efficacy of (+)‐epicatechin in subjects with Friedreich's ataxia: A phase II, open‐label, prospective study. Journal of inherited metabolic disease. 44 (2), pp. 502-514. [Online].